The mu opiate receptor (OR) has been identified as the principal brain receptor site best correlated with the rewarding and euphoric properties of opiate drugs. Euphoric responses to rapid administration of morphine and heroin can be much more prominent than those that follow slower rates of administration. Receptor phosphorylation is thought to play a role in processes which may contribute to rate- sensitivity of opiate receptor responses, and possibly to tolerance to opiates. This year investigators in this Branch have documented direct phosphorylation of the muOR, with distinct patterns driven by protein kinase C and by agonist occupancy of the receptor. They have also continued to assess the roles of specific receptor sequences in functional properties. Attention focused on the His 297 amino acid, at which replacements can confer agonist properties on mu antagonists such as naloxone. These studies are important for defining molecular features important for intrinsic activity and for patterns of heterologous and homologous desensitization of the principal opiate receptor subtype implicated in reward and in analgesia. They have used knockout/homologous recombination strategies to delete half- or all of the mu receptor expression in vivo, and identified surprising influences on baseline pain behaviors and influences of morphine, heroin, as well as agonists at delta and kappa receptors. - morphine heroin - Human Subjects: Interview, Questionaires, or Surveys Only

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000406-03
Application #
6289614
Study Section
Special Emphasis Panel (MNB)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Hashimoto, Keisuke; Amano, Taku; Kasakura, Akiko et al. (2009) mu-Opioid receptor-independent fashion of the suppression of sodium currents by mu-opioid analgesics in thalamic neurons. Neurosci Lett 453:62-7
Ide, Soichiro; Minami, Masabumi; Ishihara, Kumatoshi et al. (2008) Abolished thermal and mechanical antinociception but retained visceral chemical antinociception induced by butorphanol in micro-opioid receptor knockout mice. Neuropharmacology 54:1182-8
Harburg, G C; Hall, F S; Harrist, A V et al. (2007) Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. Neuroscience 144:77-87
Job, Martin O; Tang, Amanda; Hall, F Scott et al. (2007) Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasis. Biol Psychiatry 62:627-34
Han, Wenhua; Hata, Harumi; Imbe, Hiroki et al. (2006) Increased body weight in mice lacking mu-opioid receptors. Neuroreport 17:941-4
Wu, Hsiang-en; Sun, Han-Sen; Terashivili, Maia et al. (2006) dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice. Eur J Pharmacol 531:103-7
Yamada, Hiroaki; Shimoyama, Naohito; Sora, Ichiro et al. (2006) Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Brain Res 1083:61-9
Ide, Soichiro; Minami, Masabumi; Ishihara, Kumatoshi et al. (2006) Mu opioid receptor-dependent and independent components in effects of tramadol. Neuropharmacology 51:651-8
Kasai, Shinya; Han, Wenhua; Ide, Soichiro et al. (2006) Involvement of the 3' non-coding region of the mu opioid receptor gene in morphine-induced analgesia. Psychiatry Clin Neurosci 60 Suppl 1:S11-7
Han, Wenhua; Kasai, Shinya; Hata, Harumi et al. (2006) Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity. Pharmacogenet Genomics 16:451-60

Showing the most recent 10 out of 18 publications